By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

News Junction

Notification Show More
Font ResizerAa
  • Home
  • World News
    World NewsShow More
    Gaza hospital attack: Analysis contradicts Israel’s evidence justifying airstrike | World News
    Gaza hospital attack: Analysis contradicts Israel’s evidence justifying airstrike | World News
    May 15, 2025
    For U.S. Defense Industry, These Minerals Really are ‘Critical’
    For U.S. Defense Industry, These Minerals Really are ‘Critical’
    May 14, 2025
    Did the US flinch first in tariff war with China? | Trade War News
    Did the US flinch first in tariff war with China? | Trade War News
    May 14, 2025
    Saudis use burgers to impress Trump (VIDEO) — RT World News
    Saudis use burgers to impress Trump (VIDEO) — RT World News
    May 14, 2025
    Sony shares rise in choppy trade as PlayStation maker announces .7 billion share buyback
    Sony shares rise in choppy trade as PlayStation maker announces $1.7 billion share buyback
    May 14, 2025
  • Business
    BusinessShow More
    Ukraine blows up bridges to consolidate its positions in Russia
    Ukraine blows up bridges to consolidate its positions in Russia
    August 18, 2024
    Commentary: AI phones from Google and Apple will erode trust in everything
    Commentary: AI phones from Google and Apple will erode trust in everything
    August 18, 2024
    The most famous Indian Dishes – Insights Success
    The most famous Indian Dishes – Insights Success
    August 18, 2024
    Life on the road as a female long rides cyclist
    Life on the road as a female long rides cyclist
    August 18, 2024
    UK inflation rises to 2.2%
    UK inflation rises to 2.2%
    August 18, 2024
  • Cryptocurrency
    CryptocurrencyShow More
    Dan Morehead Sees Decades of Bitcoin (BTC) Upside Ahead as Pantera Bets on Broad Crypto Future
    Dan Morehead Sees Decades of Bitcoin (BTC) Upside Ahead as Pantera Bets on Broad Crypto Future
    May 15, 2025
    Price analysis 3/10: SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, PI
    Price analysis 3/10: SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, PI
    May 14, 2025
    Ethereum retakes 10% control of crypto market, but ETH bulls shouldn’t celebrate yet
    Ethereum retakes 10% control of crypto market, but ETH bulls shouldn’t celebrate yet
    May 14, 2025
    Top South Korean presidential hopefuls support legalizing Bitcoin ETFs
    Top South Korean presidential hopefuls support legalizing Bitcoin ETFs
    May 14, 2025
    Ex-SEC Chair Gary Gensler privately supported crypto — McHenry
    Ex-SEC Chair Gary Gensler privately supported crypto — McHenry
    May 14, 2025
  • Technology
    TechnologyShow More
    How to Improve Your Spotify Recommendations
    How to Improve Your Spotify Recommendations
    August 18, 2024
    X says it’s closing operations in Brazil
    X says it’s closing operations in Brazil
    August 18, 2024
    Supermoon set to rise: Top tips for amateur photographers | Science & Tech News
    Supermoon set to rise: Top tips for amateur photographers | Science & Tech News
    August 18, 2024
    Scientists Want to See Videos of Your Cat for a New Study
    Scientists Want to See Videos of Your Cat for a New Study
    August 18, 2024
    OpenAI’s new voice mode let me talk with my phone, not to it
    OpenAI’s new voice mode let me talk with my phone, not to it
    August 18, 2024
  • Entertainment
  • Sports News
  • People
  • Trend
Reading: AstraZeneca reports total voting rights By Investing.com
Share
Font ResizerAa

News Junction

  • World News
  • Business
  • Technology
  • Cryptocurrency
  • Trend
  • Entertainment
Search
  • Recent Headlines in Entertainment, World News, and Cryptocurrency – NewsJunction
  • World News
  • Business
  • Cryptocurrency
  • Technology
  • Entertainment
  • Sports News
  • People
  • Trend
Have an existing account? Sign In
Follow US
News Junction > Blog > Business > AstraZeneca reports total voting rights By Investing.com
AstraZeneca reports total voting rights By Investing.com
Business

AstraZeneca reports total voting rights By Investing.com

Published July 1, 2024
Share
5 Min Read
SHARE

AstraZeneca PLC (LSE/STO/NASDAQ:LON:), the global biopharmaceutical company, announced today that as of June 30, 2024, its issued share capital consists of 1,550,268,075 ordinary shares with voting rights. The company confirmed that no shares are currently held in Treasury, which means the total number of voting rights in the company stands at 1,550,268,075.

This figure is disclosed in accordance with the UK Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1 and will be used by shareholders to determine if they are required to notify their interest in AstraZeneca (NASDAQ:) PLC, or a change to their interest, under the Disclosure and Transparency Rules.

Headquartered in Cambridge, UK, AstraZeneca is focused on the discovery, development, and commercialization of prescription medicines, particularly in the areas of Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company’s products are available in over 125 countries and are used by millions of patients worldwide.

The information provided in this announcement is based on a press release statement from the company. AstraZeneca has a strong presence in the pharmaceutical industry, with a commitment to advancing medical science and improving the health outcomes of patients globally.

Investors and shareholders may consider this update on voting rights as part of their ongoing assessment of the company’s performance and governance. AstraZeneca’s dedication to transparency and adherence to regulatory requirements reflects its ongoing commitment to good corporate practices.

In other recent news, AstraZeneca’s drugs Lynparza and Imfinzi have received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use for treating advanced or recurrent endometrial cancers, based on the DUO-E Phase III clinical trial results.

In parallel, AstraZeneca’s Imfinzi, in combination with chemotherapy, has shown a statistically significant improvement in event-free survival and overall survival for patients with muscle-invasive bladder cancer, according to results from the NIAGARA Phase III trial. Still, Imfinzi did not meet the primary endpoint of disease-free survival in the ADJUVANT BR.31 Phase III trial for early-stage non-small cell lung cancer.

On a positive note, the U.S. Food and Drug Administration has approved AstraZeneca’s Imfinzi for treating adults with primary advanced or recurrent endometrial cancer that is mismatch repair deficient.

These developments have led analyst firms Citi, BMO Capital, and Deutsche Bank to maintain positive ratings on AstraZeneca’s shares. AstraZeneca’s CEO, Pascal Soriot, also recently transferred a significant number of shares to family members. It’s important to note that these are recent developments and are subject to change.

InvestingPro Insights

As AstraZeneca PLC (NASDAQ:AZN) continues to maintain its robust presence in the pharmaceutical industry, recent data from InvestingPro indicates a promising financial outlook for the company. With a market capitalization of $243.34 billion and a revenue growth of 8.6% over the last twelve months as of Q1 2024, AstraZeneca stands out for its financial strength. The company also boasts a high gross profit margin of 82.5%, underscoring its efficiency in maintaining profitability.

Two InvestingPro Tips that investors should consider are that AstraZeneca’s net income is expected to grow this year, and two analysts have revised their earnings upwards for the upcoming period. These insights suggest a positive trajectory for the company’s financial performance, which could influence investment decisions.

Moreover, AstraZeneca has a history of reliability for income-focused investors, having maintained dividend payments for 32 consecutive years, with a dividend yield of 2.47% as of the last recorded date.

For those interested in deeper analysis and additional insights, InvestingPro offers more tips on AstraZeneca, including the company’s trading patterns and debt management. Unlock these valuable insights and enhance your investment strategy with InvestingPro. Use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. With numerous additional tips available, investors can make more informed decisions based on comprehensive data and expert analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

#AstraZeneca #reports #total #voting #rights #Investing.com

TAGGED:AstraZenecaInvesting.comreportsrightstotalvoting
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article 18 Must-Have Beach Day Essentials 18 Must-Have Beach Day Essentials
Next Article Escalating Tensions Between China and the Philippines Could Draw the U.S. Into Conflict Escalating Tensions Between China and the Philippines Could Draw the U.S. Into Conflict
- Advertisement -

Latest Post

Gaza hospital attack: Analysis contradicts Israel’s evidence justifying airstrike | World News
Gaza hospital attack: Analysis contradicts Israel’s evidence justifying airstrike | World News
World News
Dan Morehead Sees Decades of Bitcoin (BTC) Upside Ahead as Pantera Bets on Broad Crypto Future
Dan Morehead Sees Decades of Bitcoin (BTC) Upside Ahead as Pantera Bets on Broad Crypto Future
Cryptocurrency
Price analysis 3/10: SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, PI
Price analysis 3/10: SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, PI
Cryptocurrency
For U.S. Defense Industry, These Minerals Really are ‘Critical’
For U.S. Defense Industry, These Minerals Really are ‘Critical’
World News
Ethereum retakes 10% control of crypto market, but ETH bulls shouldn’t celebrate yet
Ethereum retakes 10% control of crypto market, but ETH bulls shouldn’t celebrate yet
Cryptocurrency
Did the US flinch first in tariff war with China? | Trade War News
Did the US flinch first in tariff war with China? | Trade War News
World News
- Advertisement -

You Might Also Like

Morrisons to sell 337 petrol forecourts as part of £2.5bn deal
Business

Morrisons to sell 337 petrol forecourts as part of £2.5bn deal

January 31, 2024
From Good to Great: Enhancing Your Creative Ideas
Business

From Good to Great: Enhancing Your Creative Ideas

January 30, 2024
US Steel Starts Review as It Spurns .25 Billion Cliffs Bid
Business

US Steel Starts Review as It Spurns $7.25 Billion Cliffs Bid

August 14, 2023
What PM’s North Sea drill plan might mean for jobs – and the transition to net zero
Business

What PM’s North Sea drill plan might mean for jobs – and the transition to net zero

January 27, 2024

About Us

NEWS JUNCTION (NewsJunction.xyz) Your trusted destination for global news. Stay informed with our timely and accurate reporting on diverse topics, including politics, technology, science, entertainment, sports, and more. Count on us for unbiased and reliable updates at your fingertips.

Quick Link

  • About
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Contact

Top Categories

  • World News
  • Business
  • Technology
  • Entertainment
  • Cryptocurrency
  • Sports News
  • Trend
  • People

Subscribe

Subscribe to our newsletter to get our newest articles instantly!

    © 2023 News Junction.
    • Blog
    • Advertise
    • Contact
    Welcome Back!

    Sign in to your account

    Username or Email Address
    Password

    Lost your password?